Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Walled Off Pancreatic Necrosis (WON)
Total 0 results
Nothing found
Sponsors and Collaborators
Everett Meyer
Hospital Durand, Argentina
Aptis Medical
Apollo Neuroscience, Inc.
Eurofins Genoma
Neurophth Therapeutics Inc
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
GFI
Hospital ASEPEYO Sant Cugat
iCAD
ASST Cremona, Cremona
RMIT University, Melbourne, Australia
Alma Lasers Inc.
Kupfer, David J., M.D.
Korean Society of Spine Surgery
Agency for Science, Technology and Research
Nacuity Pharmaceuticals, Inc.
Mª Victoria Maestre Sanchez
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
View Full List
Medical Conditions
Splenic Trauma
Dienogest
Metachronous Adenoma
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Immune-Mediated Inflammatory Disease
Disorder of Fluid Balance
Treatment Decisions
Rheumatoid Arthritis(RA)
Chronic Constipation Symptoms
The Strength Properties of the Aorta in Vitro
Gastric Cancer Stage IIIB-IIIC
Recurrent Clear Cell Sarcoma of Soft Tissue
RISS Stage III Plasma Cell Myeloma
Corneal Cross-Linking
T-LGL Leukemia
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Major Liver Surgery
Luteal Phase Support
Scleredema
Fever
View Full List
Drug Interventions
Desvenlafaxine
RDX227675
Intravenous deferiprone
Capecitabine/cisplatin
Capecitabine and IMRT (if randomized to this arm)
Olopatadine
Intravenous Formulation of PD-0332991
TPN-101
PD-1/PD-L1 inhibitor
Camptosar
OnabotulinumtoxinA
Standard of care (SOC) for COVID-19
GLPG1837 multiple ascending doses
Letrozole
THC
MLN2480
Anticholinergic
Midazolam
Oxycodone/acetaminophen 5/325 mg
Fospropofol disodium, propofol
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Bahamas
Contract Research Organizations in Benin
Contract Research Organizations in Egypt
Contract Research Organizations in India
Contract Research Organizations in Jamaica
Contract Research Organizations in Kuwait
Contract Research Organizations in Lebanon
Contract Research Organizations in Mongolia
Contract Research Organizations in Panama
Contract Research Organizations in Paraguay
Contract Research Organizations in Rwanda
Contract Research Organizations in Switzerland
CRO list by country
CROs in China
Medpace
ICON
Acrovan
Shanghai Clinical Research Center (SCRC)
PPD
Charles River Laboratories
PSI
PRA Health Sciences
Proswell Medical Company
IQVIA
All CROs in China
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe